AlphaYouMR
Insider selling
Michael R Megna sold $369K of Kiniksa Pharmaceuticals International, plc (KNSA) stock
Michael R Megna, Chief Accounting Officer of Kiniksa Pharmaceuticals International, plc (KNSA), sold 4,600 shares of KNSA stock worth $369K, per an SEC Form 4 filed Sep 3, 2026.
The sale was pre-arranged (a 10b5-1 plan or an option exercise), not a fresh decision.
The trade happened on Jul 15, 2026, 50 days before it was made public.
KNSA has moved +26.4% since the trade date, from $61.69 to $78.00 (Sep 22, 2026 close).
- Traded
- Jul 15, 2026
- Disclosed
- Sep 3, 2026
- Filing delay
- 50 days
- Price since
- +26.4%
- Role
- Chief Accounting Officer
- Source
- SEC Form 4
More KNSA insider and Congress trades
From a public SEC Form 4, linked above. Not investment advice, and not a recommendation to buy or sell.